Modeling the metabolic effects of terbutaline in β2‐adrenergic receptor diplotypes

Our objective was to determine whether β2‐adrenergic receptor polymorphisms influence terbutaline‐stimulated changes in glucose, insulin, and potassium concentrations in healthy adults.

[1]  R S Judson,et al.  Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Wheatley,et al.  &bgr;2-Adrenoceptor Polymorphism Determines Vascular Reactivity in Humans , 2000, Hypertension.

[3]  L. Groop,et al.  Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. , 2001, Hypertension.

[4]  S. Liggett,et al.  Hierarchy of polymorphic variation and desensitization permutations relative to beta 1- and beta 2-adrenergic receptor signaling. , 2003, The Journal of biological chemistry.

[5]  G. Dorn,et al.  Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. , 2000, Circulation research.

[6]  J. Johnson,et al.  Simple method for determination of terbutaline plasma concentration by high-performance liquid chromatography. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[7]  Matthias Wjst,et al.  Association of β2-Adrenoreceptor Variants with Bronchial Hyperresponsiveness , 2000 .

[8]  R. Moore.  Stimulation of Na:H exchange by insulin. , 1981, Biophysical journal.

[9]  S. Liggett.  Polymorphisms of the beta2-adrenergic receptor. , 2002, The New England journal of medicine.

[10]  G. Corso,et al.  Influence of epinephrine, norepinephrine, and isoproterenol on glucose homeostasis in normal man. , 1980, The Journal of clinical endocrinology and metabolism.

[11]  Y. Kawai,et al.  Adrenergic receptors in human liver plasma membranes: predominance of beta 2- and alpha 1-receptor subtypes. , 1986, The Journal of clinical endocrinology and metabolism.

[12]  V. Large,et al.  The different effects of a Gln27Glu β2‐adrenoceptor gene polymorphism on obesity in males and in females , 1999, Journal of internal medicine.

[13]  E. Donahue,et al.  Comparison of the direct and indirect effects of epinephrine on hepatic glucose production. , 1997, The Journal of clinical investigation.

[14]  P. Matricardi,et al.  Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study. , 1998, American journal of respiratory and critical care medicine.

[15]  P. Cryer,et al.  Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. , 1980, The Journal of clinical investigation.

[16]  T. Waldron,et al.  Quantitation of tremor in response to beta-adrenergic receptor stimulation in primates: relationship with hypokalemia. , 1998, Journal of pharmacological and toxicological methods.

[17]  K. Nonogaki,et al.  New insights into sympathetic regulation of glucose and fat metabolism , 2000, Diabetologia.

[18]  Y. Kawai,et al.  Adrenergic Receptors in Human Liver Plasma Membranes: Predominance of β2- and α1-Receptor Subtypes , 1986 .

[19]  R. D. Lowrey.  Modeling strategies , 1995 .

[20]  L. Philipson.  β-Agonists and metabolism , 2002 .

[21]  C. Chu,et al.  The direct effects of catecholamines on hepatic glucose production occur via alpha(1)- and beta(2)-receptors in the dog. , 2000, American journal of physiology. Endocrinology and metabolism.

[22]  M. Kendall,et al.  The lipolytic effect of beta 1- and beta 2-adrenoceptor activation in healthy human volunteers. , 1993, British journal of clinical pharmacology.

[23]  C. Chu,et al.  The direct effects of catecholamines on hepatic glucose production occur via α1- and β2-receptors in the dog , 2000 .

[24]  K. Alberti,et al.  Regulation of glucose metabolism by norepinephrine in conscious dogs. , 1991, The American journal of physiology.

[25]  R. Rizza,et al.  Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. , 1980, The Journal of clinical investigation.

[26]  W J Jusko,et al.  Physiologic indirect response models characterize diverse types of pharmacodynamic effects , 1994, Clinical pharmacology and therapeutics.

[27]  Jianwei Wang,et al.  Determination of Human β2-Adrenoceptor Haplotypes by Denaturation Selective Amplification and Subtractive Genotyping , 2001, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[28]  F Skrabal,et al.  beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. , 1999, Hypertension.

[29]  K. Yamada,et al.  Association of polymorphisms in the β2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus (Short Communication) , 1999, Diabetologia.

[30]  R. Kim,et al.  The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. , 2001, The New England journal of medicine.

[31]  T. Clausen.  Regulation of active Na+-K+ transport in skeletal muscle. , 1986, Physiological reviews.

[32]  M. Wjst,et al.  Association of beta(2)-adrenoreceptor variants with bronchial hyperresponsiveness. , 2000, American journal of respiratory and critical care medicine.

[33]  S. Liggett,et al.  beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. , 2000, American heart journal.

[34]  L C Gatewood,et al.  Model studies of blood-glucose regulation. , 1965, The Bulletin of mathematical biophysics.

[35]  P. Cryer,et al.  Glycemic Actions of Alanine and Terbutaline in IDDM , 1993, Diabetes Care.

[36]  R. Rizza,et al.  Differential effects of epinephrine on glucose production and disposal in man. , 1979, The American journal of physiology.

[37]  N. Harris,et al.  Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. , 2003, Diabetes.

[38]  A. Koyanagi,et al.  Polymorphism in the 5'-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes. , 1999, The Journal of clinical endocrinology and metabolism.

[39]  S. Liggett,et al.  Hierarchy of Polymorphic Variation and Desensitization Permutations Relative to β1- and β2-Adrenergic Receptor Signaling* , 2003, The Journal of Biological Chemistry.

[40]  T D Weir,et al.  beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. , 1998, American journal of respiratory and critical care medicine.